MALINVERNO, MATTEO
MALINVERNO, MATTEO
DIPARTIMENTO DI SCIENZE FARMACOLOGICHE (attivo dal 01/01/2001 al 27/04/2012)
Epigenetic regulation by polycomb repressive complex 1 promotes cerebral cavernous malformations
2024 V. Pham, C.J. Rödel, M. Valentino, M. Malinverno, A. Paolini, J. Münch, C. Pasquier, F.C. Onyeogaziri, B. Lazovic, R. Girard, J. Koskimäki, M. Hußmann, B. Keith, D. Jachimowicz, F. Kohl, A. Hagelkruys, J.M. Penninger, S. Schulte-Merker, I.A. Awad, R. Hicks, P.U. Magnusson, E. Faurobert, M. Pagani, S. Abdelilah-Seyfried
Growth Differentiation Factor 6 Promotes Vascular Stability by Restraining Vascular Endothelial Growth Factor Signaling
2018 S. Krispin, A.N. Stratman, C.H. Melick, R.V. Stan, M. Malinverno, J. Gleklen, D. Castranova, E. Dejana, B.M. Weinstein
Endothelial Cells Lining Sporadic Cerebral Cavernous Malformation Cavernomas Undergo Endothelial-to-Mesenchymal Transition
2016 L. Bravi, M. Malinverno, F. Pisati, N. Rudini, R. Cuttano, R. Pallini, M. Martini, L.M. Larocca, M. Locatelli, V. Levi, G.A. Bertani, E. Dejana, M.G. Lampugnani
The neuropeptide PACAP38 induces dendritic spine remodeling through ADAM10-N-cadherin signaling pathway
2012 F. Gardoni, C. Saraceno, M. Malinverno, E. Marcello, C. Verpelli, C. Sala, M. Di Luca
Reply to "Diagnosis of progressive supranuclear palsy: can measurement of tau forms help?"
2012 B. B., F. Gardoni, M. Malinverno, P. A., M.M.G. Diluca
MOLECULAR MECHANISMS REGULATING SPINE REMODELLING
2010 M. Malinverno
Synaptic localization and activity of ADAM10 regulate excitatory synapses through N-cadherin cleavage
2010 M. Malinverno, M. Carta, R. Epis, E. Marcello, C. Verpelli, F. Cattabeni, C. Sala, C. Mulle, M. Di Luca, F. Gardoni
Blocking ADAM10 synaptic trafficking generates a model of sporadic Alzheimer's disease
2010 R. Epis, E. Marcello, F. Gardoni, C. Vastagh, M. Malinverno, C. Balducci, A. Colombo, B. Borroni, H. Vara, M. Dell'Agli, F. Cattabeni, M. Giustetto, T. Borsello, G. Forloni, A. Padovani, M. Di Luca
A combination of CSF tau ratio and midsaggital midbraintopons atrophy for the early diagnosis of progressive supranuclear palsy
2010 B. Borroni, M. Malinverno, F. Gardoni, M. Grassi, L. Parnetti, C. Agosti, A. Alberici, E. Premi, U. Bonuccelli, R. Gasparotti, P. Calabresi, M. Di Luca, A. Padovani
An innovative model for Alzheimer’s disease
2009 R. Epis, E. Marcello, H.V. Rivera, A. Colombo, C. Balducci, M. Malinverno, G. Forloni, T. Borsello, M. Giustetto, F. Gardoni, M. Di Luca
Decreased NR2B Subunit Synaptic Levels Cause Impaired Long-Term Potentiation But Not Long-Term Depression
2009 F. Gardoni, D. Mauceri, M. Malinverno, F. Polli, C. Costa, A. Tozzi, S. Siliquini, B. Picconi, F. Cattabeni, P. Calabresi, M. Di Luca
ADAM10 regulates dendritic spine morphology and glutamate receptor composition trough N-Cadherin cleavage
2009 M. Malinverrno, F. Gardoni, M. Carta, C. Sala, C. Mulle, F. Cattabeni, M. Di Luca, M. Malinverno
An innovative model to study Alzheimer’s disease
2009 R. Epis, E. Marcello, H.V. Rivera, A. Colombo, C. Balducci, M. Malinverno, G. Forloni, T. Borsello, M. Giustetto, F. Gardoni, M. Di Luca
Synaptic localization of GluR1 is regulated by ADAM10 trafficking and N-Cadherin cleavage
2009 M. Malinverno, F. Gardoni, C. Sala, M. Carta, C. Mulle, M. Di Luca
Pattern of Tau forms in CSF is altered in progressive supranuclear palsy
2009 B. Borroni, F. Gardoni, L. Parnetti, L. Magno, M. Malinverno, E. Saggese, P. Calabresi, M.G. Spillantini, A. Padovani, M. Di Luca
ADAM10 regulates dendritic spine morphology and glutamate receptor composition trough N-Cadherin cleavage
2008 M. Malinverno, F. Gardoni, C. Sala, F. Cattabeni, M. Di Luca
ADAM10 regulates dendritic spine morphology and glutamate receptor composition trough N-Cadherin cleavage
2008 M. Malinverno, F. Gardoni, C. Sala, F. Cattabeni, M. Di Luca
Tau forms in CSF as a reliable biomarker for progressive supranuclear palsy
2008 B. Borroni, M. Malinverno, F. Gardoni, A. Alberici, L. Parnetti, E. Premi, U. Bonuccelli, M. Grassi, D. Perani, P. Calabresi, M. Di Luca, A. Padovani
A critical interaction between NR2B and MAGUK in L-DOPA induced dyskinesia
2006 M. Malinverno, F. Gardoni, B. Picconi, V. Ghiglieri, F. Polli, V. Bagetta, G. Bernardi, F. Cattabeni, M. Di Luca, P. Calabresi